Patents by Inventor Go-Eun SHIN

Go-Eun SHIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lactobacillus brevis G-101 strain and use thereof
    Patent number: 10004769
    Abstract: The present invention relates to a novel Lactobacillus brevis G-101 strain capable of decomposing monosodium L-glutamate (MSG), and a functional health food, a pharmaceutical composition, or a food product comprising the same as an active ingredient. More specifically, the strain is effective in reducing in vivo blood MSG levels of animals and attenuating MSG Symptom Complex, and thus can be used in a functional health food, a pharmaceutical composition, or a food product aiming to prevent in vivo absorption of MSG, which is known to be harmful, and improve the MSG Symptom Complex.
    Type: Grant
    Filed: June 2, 2014
    Date of Patent: June 26, 2018
    Assignee: CTC BIO, INC.
    Inventors: Hong Ryeol Jeon, Yoon-Mo Kang, Byeong-Gon Lee, Se-Young Kim, Go-Eun Shin
  • LACTOBACILLUS BREVIS G-101 STRAIN AND USE THEREOF
    Publication number: 20160129057
    Abstract: The present invention relates to a novel Lactobacillus brevis G-101 strain capable of decomposing monosodium L-glutamate (MSG), and a functional health food, a pharmaceutical composition, or a food product comprising the same as an active ingredient. More specifically, the strain is effective in reducing in vivo blood MSG levels of animals and attenuating MSG Symptom Complex, and thus can be used in a functional health food, a pharmaceutical composition, or a food product aiming to prevent in vivo absorption of MSG, which is known to be harmful, and improve the MSG Symptom Complex.
    Type: Application
    Filed: June 2, 2014
    Publication date: May 12, 2016
    Inventors: Hong Ryeol JEON, Yoon-Mo KANG, Byeong-Gon LEE, Se-Young KIM, Go-Eun SHIN